#	Pagina
attuale pagina	/open-h2020/projects/223617/index.html
-1	/open-h2020/projects/206728/results.html
-2	/open-h2020/per-topic/remotea/list/index.html

Opendata, web and dolomites

DIABETESMART

The first Clinically Validated AI-powered Diabetes Assistant

Total Cost €

EC-Contrib. €

Partnership

Views

DIABETESMART project word cloud

Explore the words cloud of the DIABETESMART project. It provides you a very rough idea of what is the project "DIABETESMART" about.

obtain 19 11 life class 69 country people 26 mission diabetes mobile live ai 2040 lifestyle fatal powered self million normal time platform health device 81 globally medical 2016 validated 2017 blood 25 18m sugar clinically start phone bellow 642 2026 cumulative children prevalence care individuals glucose hedia 415 wearable market revenues benefit diagnosed easier team improvement foresee insights 2045 profits recommendations chronic 12 28 outperforms stat 200 employees 2021 complications danish thousand corporates provides 2022 10b physician 28b diabetesmart cagr 4 66 disease pioneer patient context mellitus mdr potentially integrate estimate compliant iia founded 75 daily europes least intelligent shown artificial app company 137 forecast 2015 clinical

Project "DIABETESMART" data sheet

The following table provides information about the project.

Coordinator	HEDIA IVS Organization address address: OLE MAALOES VEJ 3 city: KOBENHAVN postcode: 2200 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Denmark [DK]
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
Code Call	H2020-SMEInst-2018-2020-1
Funding Scheme	SME-1
Starting year	2019
Duration (year-month-day)	from 2019-05-01 to 2019-08-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	HEDIA IVS HEDIA IVS Organization address address: OLE MAALOES VEJ 3 city: KOBENHAVN postcode: 2200 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DK (KOBENHAVN)	coordinator	50˙000.00

Map

Project objective

Diabetes mellitus, a common chronic disease that is associated with high blood glucose (also called blood sugar) can lead to potentially fatal health complications. Globally, 415 million people were diagnosed with diabetes in 2015, estimated to reach 642 million by 2040. In Europe disease prevalence is high, 66 million people were diagnosed in 2017, estimate to reach 81 million people by 2045, with 28,200 children (bellow 19 years old) diagnosed each year. Diabetes requires long-life care management from a physician care team and patient daily self-management. Improvement of diabetes self-care was shown when people with diabetes used mobile phone application. Yet, the challenge is to identify a clinical relevant App between the thousand diabetes management applications available in the market. Hedia, a Danish pioneer start-up company was founded with the mission to make life easier for people with diabetes. Based on the current challenges, we have developed a mobile platform for the daily diabetes management that outperforms the current stat-of-the-art: clinically validated Class IIA compliant to Europes’s new MDR; an artificial intelligent powered that provides tailored recommendations based on the individuals lifestyle and country context; integrate the user’s blood medical device and wearable of choice and other advanced features that enable people with diabetes live a normal life. DIABETESMART project targets the diabetes care market, which has an estimate value of €69.10B in 2016, forecast to reach €137.28B by 2022 with a 12.4% CAGR (2016-2022). We aim to offer DIABETESMART to corporates -who will obtain further revenues of €18M per year- and to people with diabetes who will benefit from real-time clinically meaningful insights based on AI by 2021. We foresee to reach revenues of €26.6 million with €75.1 million in cumulative profits and increase our team to at least 25 employees (from current 11) by 2026.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DIABETESMART" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DIABETESMART" are provided by the European Opendata Portal: CORDIS opendata.